Residential College | false |
Status | 已發表Published |
CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species | |
Zheng, Linggang1,2; Tan, Yang1; Hu, Yucan1,4; Shen, Juntao1; Qu, Zepeng1,2; Chen, Xianbo1; Ho, Chun Loong3; Leung, Elaine Lai Han2; Zhao, Wei1; Dai, Lei1,4 | |
2022-01-06 | |
Source Publication | ACS Synthetic Biology |
Volume | 11Issue:1Pages:464-472 |
Abstract | Bacteroides is the most abundant genus in the human gut microbiome and has been increasingly used as model organisms for studying the function and ecology of the gut microbiome. However, genome editing tools for such commensal gut microbes are still lacking. Here we developed a versatile, highly efficient CRISPR/Cas-based genome editing tool that allows markerless gene deletion and insertion in human gut Bacteroides species. We constructed multiple CRISPR/Cas systems in all-in-one Bacteroides–E. coli shuttle plasmids and systematically evaluated the genome editing efficiency in Bacteroides thetaiotaomicron, including the mode of Cas protein expression (constitutive, inducible), different Cas proteins (FnCas12a, SpRY, SpCas9), and sgRNAs. Using the anhydrotetracycline (aTc)-inducible CRISPR/FnCas12a system, we successfully deleted large genomic fragments up to 50 kb to study the function of metabolic gene clusters. Furthermore, we demonstrated that CRISPR/FnCas12a can be broadly applied to engineer multiple human gut Bacteroides species, including Bacteroides fragilis, Bacteroides ovatus, Bacteroides uniformis, and Bacteroides vulgatus. We envision that CRISPR/Cas-based genome editing tools for Bacteroides will greatly facilitate mechanistic studies of the gut commensal and the development of engineered live biotherapeutics. |
Keyword | Bacteroides Cas12a Crispr/cas Engineered Live Biotherapeutics Genome Editing Human Gut Microbiome |
DOI | 10.1021/acssynbio.1c00543 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Biochemistry & Molecular Biology |
WOS Subject | Biochemical Research Methods |
WOS ID | WOS:000742201800001 |
Publisher | AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, DC 20036 |
Scopus ID | 2-s2.0-85123814075 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Corresponding Author | Tan, Yang; Dai, Lei |
Affiliation | 1.CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Shenzhen, 518055, China 2.Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery/State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, 999078, Macao 3.Department of Biomedical Engineering, Southern University of Science and Technology (SUSTech), Shenzhen, 518055, China 4.University of Chinese Academy of Sciences, Beijing, 100049, China |
First Author Affilication | University of Macau |
Recommended Citation GB/T 7714 | Zheng, Linggang,Tan, Yang,Hu, Yucan,et al. CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species[J]. ACS Synthetic Biology, 2022, 11(1), 464-472. |
APA | Zheng, Linggang., Tan, Yang., Hu, Yucan., Shen, Juntao., Qu, Zepeng., Chen, Xianbo., Ho, Chun Loong., Leung, Elaine Lai Han., Zhao, Wei., & Dai, Lei (2022). CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species. ACS Synthetic Biology, 11(1), 464-472. |
MLA | Zheng, Linggang,et al."CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species".ACS Synthetic Biology 11.1(2022):464-472. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment